Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
This writer and publication are not in the business of endorsing specific commercial programs, but the "Legal Mocktail" program is so well-aligned with the objectives of this column that we decided to provide a brief overview and then let the readers decide for themselves.
Transitioning a full website to a mobile website is one of the most important and strategic moves that firms are making. And if done correctly and strategically, it could be extremely profitable.
Features
Criteria for entering this year's Seventh Annual MLF 50 ' AND the brand-new Magnificent 25!
Highlights of the latest insurance cases from around the country.
Features
This article focuses on how one state, Maryland, has chosen to address first-party bad faith claims arising out of property and casualty insurance policies. Maryland's experience handling these disputes teaches lessons to both carriers and insureds.
Features
Lawyers for GlaxoSmithKline (GSK) were enjoying something of a winning streak in their efforts to remove drug product liability lawsuits to federal court ' and keep them there ' by arguing that it has converted to a limited liability company that is based in Delaware. But that streak may now be over.
Features
An in-depth review of recent litigation that affects this practice area.
Features
The heightened pleading requirements of <i>Bell Atlantic Corp. v. Twombly</i> require that practitioners who plan to file a complaint in a medical device case be even more cautious than usual. Otherwise, they may be subject to a dismissal on the pleadings.
Medical experts testifying about causation in toxic tort, medical device, and pharmaceutical litigation frequently claim to base opinions upon a dispassionate review of the scientific literature, the same analysis they perform in their clinical practices. But peeling back the fa'ade often reveals that they have done nothing of the kind.